Lupus Therapeutics, filial de Lupus Research Alliance, desarrolla un estudio que se enfoca en los pacientes con lupus y la COVID-19
7 de abril de 2020
Nueva York, NY, 7 de abril de 2020 – Lupus Therapeutics, la filial de ensayos...
Stories & News
Lupus and COVID-19:What You Need to Know Webcast on Video
April 3, 2020
The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people with...
LRA Urges Congress to Ensure Lupus Patients Maintain Access to Hydroxychloroquine
April 3, 2020
The President and CEO of the LRA, Kenneth Farber wrote personally to Speaker Nancy Pelosi and Leader...
Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis
April 1, 2020
An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus nephritis...
New Awardees Announced by the Lupus Research Program that Advocates Helped Create
April 1, 2020
Thirteen new applications for promising scientific studies were just recommended for funding through the Lupus Research Program...
The U.S. Department of Health and Human Services Accepts Donations of Hydroxychloroquine as Possible Treatments for COVID-19 Patients
March 31, 2020
A statement issued March 29 by the U.S. Department of Health and Human Services (HHS) announced that...
Actions from Pharmaceutical Companies to Preserve Hydroxychloroquine (Plaquenil) Supply
March 30, 2020
The rheumatology community has been in discussions with the U.S. Food and Drug Administration and many pharmaceutical...
DECLARACIÓN DEL 26 DE MARZO: La Alianza para la investigación de Lupus pone en perspectiva la escasez de Plaquenil (hidroxicloroquina) para la comunidad con lupus
26 de marzo de 2020
La Alianza para la investigación de Lupus (LRA), la principal organización de investigación del mundo...
CVS Preserving Plaquenil Supply for Patients Taking It
March 26, 2020
CVS put out the following statement yesterday assuring its clients that the company is protecting a supply...
LRA Sponsors COVID-19 Global Rheumatology Alliance
March 25, 2020
LRA Sponsors COVID-19 Global Rheumatology Alliance
The LRA is proud to be among the sponsors of the COVID-19...
Hidroxicloroquina: fármaco típico para tratar el Lupus a prueba para el COVID-19
19 de marzo de 2020
En diciembre de 2019, se identificó un nuevo virus llamado SARS-COV-2 en Wuhan, China. Se...
Hydroxychloroquine: Common Lupus Drug in Testing for COVID-19
March 19, 2020
In December 2019, a new virus called SARS-COV-2 was identified in Wuhan, China. This virus was found...